Literature DB >> 10027514

Effects of haloperidol treatment on prolactin response to D-fenfluramine challenge in acute schizophrenia.

P Mohr1, J Horácek, L Motlová, J Libiger, P Czobor.   

Abstract

We have previously described an association between higher serotonin (5-HT) responsivity, indexed by prolactin response to D-fenfluramine challenge, and poorer treatment response to haloperidol in non-medicated schizophrenics. The aim of the present study was to investigate the effects of antidopaminergic treatment on the prolactin response in the repeated challenge test. D-Fenfluramine was administered to 22 young, acutely ill schizophrenics (11 females and 11 males) after 4 weeks of haloperidol treatment. Whereas neuroleptic administration significantly raised basal prolactin levels (P < 0.0001), subsequent D-fenfluramine challenge produced an additional significant increase (P < 0.001). Moreover, the magnitude of this increase was not different from the pretreatment response. Our results demonstrate that prolactin response to the challenge is mediated through the 5-HT system. An observed negative association between posttreatment prolactin response and therapeutic response to haloperidol did not reach statistical significance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027514     DOI: 10.1007/s002130050840

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  1 in total

1.  A novel antipsychotic, perospirone, has antiserotonergic and antidopaminergic effects in human brain: findings from neuroendocrine challenge tests.

Authors:  M Iwakawa; T Terao; A Soya; H Kojima; Y Inoue; N Ueda; R Yoshimura; J Nakamura
Journal:  Psychopharmacology (Berl)       Date:  2004-05-25       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.